๐ ๐๐จ๐ฎ๐ง๐ญ๐๐จ๐ฐ๐ง ๐ญ๐จ ๐ญ๐ก๐ ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ! Here is a first look at another workshop powering the ๐๐ฎ๐ ๐๐ข๐๐ ๐๐๐ข๐๐ง๐๐๐ฌ ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐๐๐๐.
Europe is at a critical juncture in the global biotech race. With competition for investment, talent and innovation intensifying, how can Europe turn its world-class science into commercial success?
At the Zug Life Sciences Summit 2026, ๐๐จ๐ฏ๐ข๐ง๐ ๐ญ๐จ๐ง & ๐๐ฎ๐ซ๐ฅ๐ข๐ง๐ ๐๐๐ will host an interactive workshop:
๐๐ง๐ฏ๐๐ฌ๐ญ๐ข๐ง๐ ๐ข๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐๐๐ง ๐๐ข๐จ๐ญ๐๐๐ก ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง
Drawing on perspectives across regulation, investment and market access, this session will explore what Europe needs to remain globally competitive: from the European Biotech Act and new sources of international capital to creating the right environment for biotech companies to grow, scale and invest.
Expect:
ย โ Insights into the European Biotech Act and regulatory reform
ย โ Perspectives on global investment and new sources of biotech capital
ย โ Insights into how pricing and market access shape investment decisions
ย โ Learnings from U.S. biotech companies expanding into European hubs
ย โ Lessons from China on turning innovation into commercial success
๐ Register today atย https://lnkd.in/enH5xurQย to join us for this and other expert-led sessions at the 2026 Zug Life Sciences Summit.ย
